Clinical trial
Age-dependent Heterogeneity in the Efficacy of Prophylaxis With Enoxaparin Against Catheter-associated Thrombosis in Critically Ill Children
NCT04924322 is registered in ClinicalTrials.gov with Yale University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Age-dependent Heterogeneity in the Efficacy of Prophylaxis With Enoxaparin Against Catheter-associated Thrombosis in Critically Ill Children
- Lead sponsor
- Yale University
- Phase
- Phase 2/3
- Overall status
- Recruiting
- Start date
- May 11, 2022
- Completion date
- August 31, 2027
- Enrollment
- 258 (estimated)
- Sites
- 22
Conditions
As the registry lists them; a condition with its own page is linked.
deep venous thrombosis